Janney Montgomery Scott LLC Gilead Sciences, Inc. Transaction History

Janney Montgomery Scott LLC

$33.6 Billion
Q1 2024

A detailed history of Janney Montgomery Scott LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 224,586 shares of GILD stock, worth $15 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

224,586

Previous 231,819 3.12%

Holding current value

$15 Million

Previous $18.8 Million 12.4%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$71.58 - $87.29 $517,738 - $631,368	-7,233 Reduced 3.12%	224,586 $16.5 Million
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $774,976 - $878,842	10,577 Added 4.78%	231,819 $18.8 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $4.51 Million - $4.93 Million	61,052 Added 38.11%	221,242 $16.6 Million
Q2 2023 Jul 26, 2023	SELL	$76.01 - $86.7 $575,851 - $656,839	-7,576 Reduced 4.52%	160,190 $12.3 Million
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $1.7 Million - $1.93 Million	-21,951 Reduced 11.57%	167,766 $13.9 Million

Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $3.56 Million - $5.11 Million	-57,134 Reduced 23.15%	189,717 $16.3 Million
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $1.55 Million - $1.77 Million	26,023 Added 11.78%	246,851 $15.2 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $1.21 Million - $1.36 Million	20,907 Added 10.46%	220,828 $13.7 Million
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $69,098 - $86,587	-1,193 Reduced 0.59%	199,921 $11.9 Million
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $1.47 Million - $1.67 Million	-22,708 Reduced 10.15%	201,114 $14.6 Million
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $495,829 - $534,944	-7,325 Reduced 3.17%	223,822 $15.6 Million
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $1.51 Million - $1.65 Million	23,772 Added 11.46%	231,147 $15.9 Million
Q1 2021 Apr 27, 2021	BUY	$60.0 - $68.46 $351,540 - $401,107	5,859 Added 2.91%	207,375 $13.4 Million
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $1.31 Million - $1.49 Million	-23,109 Reduced 10.29%	201,516 $11.7 Million
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $971,181 - $1.22 Million	-15,639 Reduced 6.51%	224,625 $14.2 Million
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $1.52 Million - $1.76 Million	21,010 Added 9.58%	240,264 $18.5 Million
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $57,556 - $73,722	919 Added 0.42%	219,254 $16.4 Million
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $808,947 - $889,815	-13,128 Reduced 5.67%	218,335 $14.2 Million
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $1.55 Million - $1.72 Million	24,873 Added 12.04%	231,463 $14.7 Million
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $482,214 - $540,747	7,794 Added 3.92%	206,590 $14 Million
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $1.61 Million - $1.8 Million	25,689 Added 14.84%	198,796 $12.9 Million
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $291,923 - $380,938	4,822 Added 2.87%	173,107 $10.8 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $576,583 - $638,383	-8,089 Reduced 4.59%	168,285 $13 Million
Q2 2018 Jul 24, 2018	SELL	$64.88 - $75.68 $1.37 Million - $1.6 Million	-21,150 Reduced 10.71%	176,374 $12.5 Million
Q1 2018 Apr 19, 2018	SELL	$72.84 - $88.8 $1.49 Million - $1.82 Million	-20,458 Reduced 9.39%	197,524 $14.9 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.9 Million - $2.23 Million	-26,668 Reduced 10.9%	217,982 $15.6 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $17.6 Million - $20.9 Million	244,650	244,650 $19.8 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Gilead Sciences, Inc. Transaction History